A pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatment
Yükleniyor...
Dosyalar
Tarih
2016
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Elsevier Ireland Ltd
Erişim Hakkı
info:eu-repo/semantics/embargoedAccess
Özet
Cisplatin is an antitumor drug widely used in the treatmentof many malignant tumors. And also some studies show thatmelatonin and curcumin have antitumor activity via several mech-anisms including theirs in addition to theirs potent antioxidantactions. This study was performed to evaluate the effect of cur-cumin and melatonin on the cytotoxicity induced by cisplatin inthe human breast cancer cell line (MCF-7). The cells were treatedwith melatonin or cisplatin or curcumin for 24 and 48 h. Cellviability was quantified using the 3-(4,5-dimethyl-2-thiazolyl)-
Açıklama
52nd Congress of the European-Societies-of-Toxicology (EUROTOX) -- SEP 04-07, 2016 -- Seville, SPAIN
WOS: 000402436700390
WOS: 000402436700390
Anahtar Kelimeler
Pharmacy, Pharmaceutical Toxicology
Kaynak
52nd Congress of the European-Societies-of-Toxicology (EUROTOX)
WoS Q Değeri
Q2
Scopus Q Değeri
Cilt
258
Sayı
Supplement: S
Künye
Özdatlı, Ş., Kaşıkçıoğlu G., Göçmen, E., Rüzgar, M. ve Omurtag, G. (2016). A pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatment. 52nd Congress of the European-Societies-of-Toxicology (EUROTOX) içinde (S132-S133. ss.). Seville, Spain, September 04-07, 2016. https://dx.doi.org/10.1016/j.toxlet.2016.06.1522











